Biotechnology
Filter News
Found 46,695 articles
-
Biocom Applauds Introduction of Rare Disease Fund Act
9/18/2018
Biocom, the association representing the life science industry of California, today applauded the introduction of H.R. 6801, the Rare Disease (RaD) Fund Act by U.S. Representatives Juan Vargas (D-CA), Scott Peters (D-CA) and Tom Rooney (R-FL).
-
Dr. Doug Rex Hosts Live Webinar on ENDOCUFF VISION®
9/18/2018
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today it is hosting an upcoming live webinar entitled "Mechanically Enhanced Colonoscopy - Master the Art of Unfolding", presented by Dr. Doug Rex. The webinar will be presented on September 20, 2018 at 5:00 PM EST.
-
GB Sciences' Dr. Andrea Small-Howard, Chief Science Officer, Will Be Moderating a Panel Discussion; Cannabis Is Medicine; at the State of Cannabis Conference on the Queen Mary
9/18/2018
GB Sciences, Inc. (OTCQB: GBLX) announces that Dr. Andrea Small-Howard will be moderating the panel discussion which kicks-off the "Cannabis Is Medicine Track" and explores important Research Initiatives.
-
Chardan Advises NovellusDX in Cross-Border Biotech Merger
9/18/2018
Chardan, a global investment bank, announced today that the firm acted as exclusive financial advisor to NovellusDx., a leader in functional genomics, for the firm's agreement to merge with a newly formed Israeli subsidiary of Cancer Genetics, Inc.. (NASDAQ: CGIX).
-
Medicago officially starts the construction of its site in Estimauville's Innovation Area
9/18/2018
Medicago, a Canadian biotech company and global leader in the development and production of plant-based vaccines, is enthusiastically breaking ground for its commercial vaccine production facility today with the presence of Mr. Masayuki Mitsuka, President & CEO of Mitsubishi Tanabe Pharma Corporation and Mr. Regis Labeaume, Mayor of Quebec City and Medicago's employees.
-
Former Inogen CEO, Ray Huggenberger, Joins Ebb Therapeutics Board of Directors
9/18/2018
Ebb Therapeutics announces that its added Ray Huggenberger to its Board of Directors.
-
Just Biotherapeutics Announces Product Development and Manufacturing Agreement with Pandion Therapeutics
9/18/2018
Just will apply its fully integrated technology platform to accelerate Pandion’s promising drug candidates through development and into the clinic
-
SomaGenics' Strengthens Its IP and Technology Position in Small RNA Analysis and Biomarker Discovery With New Patent and Publication
9/18/2018
SomaGenics announced today the issue of US Patent 10,041,107, a continuation of SomaGenics' patent family entitled "Methods and Compositions for Detection of small RNAs."
-
Harpoon Therapeutics Announces Appointments to Board of Directors and Management Team
9/18/2018
Jonathan Drachman, M.D., former CMO of Seattle Genetics, Brings Immuno-Oncology Expertise to Board.
-
The Morgan Stanley Global Healthcare Conference ran from September 12 through 14, with numerous biopharma companies making presentations, updating their operations and pipeline activities. Here’s a look a few of the highlights.
-
CRISPR Therapeutics and ViaCyte are collaborating to discover, develop and commercialize a gene-edited allogeneic stem cell therapy or therapies for diabetes.
-
Shares of Cambridge, Mass.-based Mersana Therapeutics are up more than 7 percent in premarket trading after the company announced that it will be able to continue with its Phase I trial studying the antibody drug conjugate XMT-1522 as a potential treatment for some breast cancer patients.
-
Movers and Shakers for Sept. 17
9/17/2018
Let's take a look at some of the professionals moving to transition the pharma and biotech world this past week. -
BIA Separations Expands with New Upstream Processing Facility
9/17/2018
Investment in new lab will support integrated optimisation of upstream and downstream process development
-
Lyra Therapeutics to Present Clinical Data from Phase 1 Study of LYR-210 for the Treatment of Chronic Rhinosinusitis
9/17/2018
Results for LYR-210 study to be presented at the 64th Annual Meeting of the American Rhinologic Society
-
Realm Therapeutics Provides Corporate Update and Hires Advisor to Support Strategic Review including Formal Sale Process
9/17/2018
Realm Therapeutics plc today provides a corporate update following the August 14, 2018 announcement of top-line results of the Company's Phase 2 trial of PR022 in Atopic Dermatitis
-
DOJ Closes Investigation of Sinovac
9/17/2018
Sinovac Biotech Ltd. today announced that the U.S. Department of Justice ("DOJ") has closed its investigation, with no charges, into possible violations of the Foreign Corrupt Practices Act related to allegations that certain Sinovac employees made improper payments to Chinese government officials.
-
Navidea Biopharmaceuticals Announces Acceptance into the National Institutes of Health Commercialization Accelerator Program
9/17/2018
Navidea Biopharmaceuticals, Inc. announced today acceptance into the National Institutes of Health (“NIH”) Commercialization Accelerator Program (“CAP”) 2018-2019.
-
Navidea Biopharmaceuticals Announces Closing of a $3 Million Private Placement
9/17/2018
Navidea Biopharmaceuticals, Inc. announced today closing of a $3 million private placement.
-
Thompson Street Capital Partners Acquires LifeSpan Biosciences, Inc.
9/17/2018
Thompson Street Capital Partners has partnered with management to acquire Seattle-based LifeSpan Biosciences, Inc.